TABLE 3.
Severity of disease and outcome
| Parametera | Patient treatment
|
P | |
|---|---|---|---|
| Levofloxacin (n = 16) | Ceftriaxone (n = 16) | ||
| No. of patients with bilobar Rx involvement (%) | 6 (37.5) | 5 (31.3) | 0.5 |
| No. of patients with pleural effusion/total number of patients (%) | 4/16 (25) | 2/16 (12.5) | 0.3 |
| No. of patients with empyema (%) | 1 (6.3) | 2 (12.5) | 1 |
| No. of patients with PSI class IV (%) | 11 (68.8) | 9 (56.3) | 0.7 |
| No. of patients with PSI class V (%) | 2 (12.5) | 5 (31.3) | 0.39 |
| Mean APACHE score (SD) | 14.5 (3.8) | 14.8 (4.9) | 0.8 |
| No. of patients with shock | 1 (6.3) | 2 (12.5) | 1 |
| No. of patients with ICU admission | 0 | 2 (12.5) | 0.4 |
| No. of patients with mechanical ventilation | 0 | 2 (12.5) | 0.4 |
| Mean length of hospital stay in days (SD) | 8.44 (3.1) | 12.06 (8.9) | 0.1 |
| 30-day mortality (%) | 0 | 1 (6.3) | 1 |
ICU, intensive care unit.